How metastatic cancer causes leaky blood vessels
06 Dec 2022
Researchers examine the local communication between endothelial cells and tumors cells and its effects on endothelial cell orientation. The approach uses co-cultured human umbilical vein endothelial cells and breast epithelial tumor cell lines to simulate the tumor-endothelial interaction. The group found the clockwise chirality of the hUVECs was less affected by local hormone signaling and more so by direct physical contact with tumor cells. Specific proteins on the tumor cell binding to others on endothelial cells appeared to play a role in changing the clockwise chirality of hUVECs.
Preventing metastasis -- the development of cancer cells beyond their original location -- remains one of the major goals of current cancer research. Most malignant tumor cells metastasize by exploiting abnormal leakage from blood vessels. New work looks to further explore the role of how the alignment of endothelial cells, which line blood vessels, plays a role in the spread of cancer.
In APL Bioengineering, by AIP Publishing, researchers from the University of Michigan-Dearborn, Rensselaer Polytechnic Institute, and the University at Albany -- SUNY developed a model that examines the local communication between endothelial cells and tumors cells and its effects on endothelial cell orientation. The approach involves the use of co-cultured human umbilical vein endothelial cells (hUVECs) and breast epithelial tumor cell lines to simulate the tumor-endothelial interaction.
"The blood vessels in tumor tissues are much leakier than those in normal tissues," said author Jie Fan. "We are curious whether the tumor cells can induce the weakening in the clockwise orientation of endothelial cells and cause them to disorganize in the vessel."
The work expands on recent findings that showed that endothelial cells have chirality, a type of mirrored-image orientation similar to right and left hands, and they tend to skew in a clockwise direction.
"We believe the strong clockwise chirality of endothelial cells is important to maintain blood vessel integrity, but unfortunately, it could be damaged/weakened by tumor cells, which may increase the risk of metastasis," Fan said. "Preserving the normal chirality could inhibit tumor transmigration by reinforcing the chirality and the integrity of the endothelial barrier of blood vessels."
To address the question, the group co-cultured hUVECs with a series of tumor cell lines with varying degrees of malignancy. They then compared how hUVECs responded when the tumor cells were directly touching them versus not. To exert such a degree of control, they employed a contact printing technique to create either donut- or figure eight-shaped micropatterns to hold the cells.
The group found the clockwise chirality of the hUVECs was less affected by local hormone signaling and more so by direct physical contact with tumor cells. Specific proteins on the tumor cell binding to others on endothelial cells appeared to play a role in changing the clockwise chirality of hUVECs.
The group was surprised by the movement of the cell types. In most models for metastasis, it is thought that tumor cells march toward blood vessels before breaking through into the bloodstream.
"We had expected the tumor cell would invade the endothelial cell," Fan said. "However, we found the endothelial cells were moving towards the tumor cell on the micropattern."
Fan said regulating this interaction holds promise for better controlling cancer metastasis and he hopes to work further on developing therapeutics toward this end.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.